1. Home
  2. CDXS vs NIU Comparison

CDXS vs NIU Comparison

Compare CDXS & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • NIU
  • Stock Information
  • Founded
  • CDXS 2002
  • NIU 2014
  • Country
  • CDXS United States
  • NIU China
  • Employees
  • CDXS N/A
  • NIU N/A
  • Industry
  • CDXS Major Chemicals
  • NIU Auto Manufacturing
  • Sector
  • CDXS Industrials
  • NIU Consumer Discretionary
  • Exchange
  • CDXS Nasdaq
  • NIU Nasdaq
  • Market Cap
  • CDXS 201.3M
  • NIU 216.7M
  • IPO Year
  • CDXS 2010
  • NIU 2018
  • Fundamental
  • Price
  • CDXS $2.27
  • NIU $3.51
  • Analyst Decision
  • CDXS Buy
  • NIU
  • Analyst Count
  • CDXS 2
  • NIU 0
  • Target Price
  • CDXS $11.00
  • NIU N/A
  • AVG Volume (30 Days)
  • CDXS 1.0M
  • NIU 958.8K
  • Earning Date
  • CDXS 08-07-2025
  • NIU 08-11-2025
  • Dividend Yield
  • CDXS N/A
  • NIU N/A
  • EPS Growth
  • CDXS N/A
  • NIU N/A
  • EPS
  • CDXS N/A
  • NIU N/A
  • Revenue
  • CDXS $49,815,000.00
  • NIU $477,578,753.00
  • Revenue This Year
  • CDXS $12.77
  • NIU $41.32
  • Revenue Next Year
  • CDXS $22.12
  • NIU $24.38
  • P/E Ratio
  • CDXS N/A
  • NIU N/A
  • Revenue Growth
  • CDXS N/A
  • NIU 26.51
  • 52 Week Low
  • CDXS $1.90
  • NIU $1.65
  • 52 Week High
  • CDXS $6.08
  • NIU $4.90
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 48.16
  • NIU 49.77
  • Support Level
  • CDXS $2.20
  • NIU $3.12
  • Resistance Level
  • CDXS $2.51
  • NIU $3.93
  • Average True Range (ATR)
  • CDXS 0.14
  • NIU 0.21
  • MACD
  • CDXS -0.00
  • NIU 0.01
  • Stochastic Oscillator
  • CDXS 42.65
  • NIU 48.15

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About NIU Niu Technologies

Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

Share on Social Networks: